Literature DB >> 32565114

Protective effect of Ganoderic acid A on adjuvant-induced arthritis.

Tao Cao1, Chuanfeng Tang2, Lezhen Xue1, Mingzhu Cui3, Dan Wang4.   

Abstract

The purpose of the experiment was to explore the effect of Ganoderic acid A (GAA) on adjuvant-induced arthritis in rats. In this study, the rat model of collagen-induced rheumatoid arthritis (CIA) was established with type II collagen plus Freund's complete adjuvant. Arthritis index, joint pathology, toe swelling, hemorheology, synovial cell apoptosis, related cytokines and JAK3/STAT3 and nuclear factor-κB (NF-κB) signaling pathway were measured in rats. We found that GAA can significantly inhibit the arthritis index, improve joint pathology, reduce toe swelling, improve blood rheology, improve synovial cell apoptosis, and restore related cytokine negative regulation JAK3/STAT3 and NF-κB signaling pathways. In conclusion, GAA has an obvious therapeutic effect on joint inflammation of toes in CIA model rats, which may be due to the regulation of JAK3/STAT3 and NF-κB signaling pathway.
Copyright © 2020 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ganoderic acid A; JAK3/STAT3; NF-κB; Rheumatoid arthritis

Mesh:

Substances:

Year:  2020        PMID: 32565114     DOI: 10.1016/j.imlet.2020.06.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Ganoderic Acid A alleviates the degeneration of intervertebral disc via suppressing the activation of TLR4/NLRP3 signaling pathway.

Authors:  Dan Wang; Xianhua Cai; Feng Xu; Hui Kang; Yanjin Li; Ruibing Feng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Ganoderic Acid A-Mediated Modulation of Microglial Polarization is Involved in Depressive-Like Behaviors and Neuroinflammation in a Rat Model of Post-Stroke Depression.

Authors:  Ling Zhang; Lei Zhang; Rubo Sui
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-14       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.